JAMA (2006) 295(13):154955.10.1001/jama.295.13.1549 2 KushnerRF
There has been no shortage of coverage on GLP-1 medications, but what exactly are they
Both peptides are also prohibited for competitive athletes under the 2026 WADA Prohibited List, treated under the S0 unapproved substances category
You notice benefits faster while using lower total doses, making treatment both more effective and more efficient
However, given that GLP-1 drugs are understood to engage the hypothalamus, the region of the brain that regulates hormones, appetite, and body temperature, the biological plausibility is real
Potential Side Effects and Considerations Retatrutide may cause side effects, especially as the dosage increases